StriderDCT is pleased to share that it has signed a Memorandum of Understanding (MoU) with Artificial Brain to jointly develop Quantum-Powered AI solutions for Clinical Research. StriderDCT brings deep domain expertise in decentralized and technology-enabled clinical trials, with a strong
Traditional clinical trials rely on a ‘one-size-fits-all approach’, requiring participants to visit physical clinical trial sites. This visit is regardless of their location, mobility, or personal circumstances. This has proven to be a significant hurdle: While historical frameworks like the
StriderDCT is Now a CDSCO-approved Clinical Research Organization (CRO) StriderDCT is now officially registered as a Clinical Research Organization (CRO) under the Central Drugs Standard Control Organization (CDSCO)— the country’s apex regulatory body for clinical trials. This registration serves as
At StriderDCT, we recognize that clinical trials are far more than a collection of protocols, datasets, and timelines—they are fundamentally about the people they’re designed to serve. In line with this philosophy, our Co‑founder, Vijay Rajan, recently took part in
We’re excited to announce a new milestone. Strider DCT has been officially certified to ISO 9001:2015 Quality Management System standards for clinical trial services. This certification marks a significant step forward in our mission to deliver high-quality, reliable, and efficient
Clinical trials are tedious, time-consuming and require robust mechanisms for ensuring patient retention in the study. For patients, frequent visits to the study site results in loss of time, efforts as well as sometimes absenteeism at work. These are few of
After understanding the blog on the definition of decentralized clinical trials (DCTs), the present blog depicts the utility of the decentralized clinical trials (DCTs) and its consolidated benefits. There are several compelling reasons that have made DCTs popular and the clinical trial industry is striving
Over the past few years, there has been a notable shift in the realm of clinical trials, marked by a significant transformation brought about by the rise of decentralized clinical trials (DCTs). These inventive methodologies harness the power of technology and engage
